ORIC Pharmaceuticals, Inc.
ORIC
$5.07
-$0.24-4.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 29.87M | 28.82M | 28.17M | 27.35M | 26.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 146.62M | 142.90M | 134.75M | 125.12M | 114.09M |
| Operating Income | -146.62M | -142.90M | -134.75M | -125.12M | -114.09M |
| Income Before Tax | -132.86M | -127.85M | -119.87M | -110.78M | -101.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -132.86 | -127.85 | -119.87 | -110.78 | -101.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -132.86M | -127.85M | -119.87M | -110.78M | -101.76M |
| EBIT | -146.62M | -142.90M | -134.75M | -125.12M | -114.09M |
| EBITDA | -145.48M | -141.79M | -133.69M | -124.06M | -113.05M |
| EPS Basic | -1.88 | -1.83 | -1.81 | -1.76 | -1.81 |
| Normalized Basic EPS | -1.18 | -1.14 | -1.13 | -1.10 | -1.13 |
| EPS Diluted | -1.88 | -1.83 | -1.81 | -1.76 | -1.81 |
| Normalized Diluted EPS | -1.18 | -1.14 | -1.13 | -1.10 | -1.13 |
| Average Basic Shares Outstanding | 282.58M | 278.89M | 265.70M | 252.56M | 227.87M |
| Average Diluted Shares Outstanding | 282.58M | 278.89M | 265.70M | 252.56M | 227.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |